Our excellence center for Chemistry, Formulation development, Analytics, Clinical Trial Supplies and Bioanalysis.
Our motivated and experienced employees are highly skilled for the development and manufacture of topical products.
Headcount: 90 employees, ex-pharma industry, 84% university graduates: 42% Bachelor degree & 42 % Master degree and PhD
Laboratories: 2.700 m²
Offices: 650 m²
Chemistry: API synthesis, process development & GMP manufacturing
Topical Formulation : development of innovative formulation
GMP manufacturing of semi liquid formulations
Clinical Trial Supplies
Quality Assurance & Regulatory Affairs services
Specialists in topical formulations for drugs and cosmetics
GMP part I and II: 2019 and 2020
GLP compliant, certification planned in 2020
ISO 22716 compliant
French Research Tax Credit (CIR) accreditation
Total result 83/100.
83 points out of a maximum of 100.
GMP and GLP compliant site was established by GALDERMA in 2006 to become the largest R&D site of the world dedicated to dermatology.
NUVISAN acquired in Sept 2018 part of these R&D competencies and launched its operations in Oct 2018.